Skip to content

Imaging-Guided Vessel Sizing in the Tibial Arteries

Imaging-Guided Vessel Sizing in the Tibial Arteries

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04748965
Acronym
iVEST
Enrollment
40
Registered
2021-02-10
Start date
2021-08-16
Completion date
2024-06-09
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease, Critical Limb Ischemia

Brief summary

This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. Secondary comparison with intravascular ultrasound (IVUS) is undertaken when clinically feasible. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.

Detailed description

This is a prospective, nonrandomized trial to investigate the adjunctive use of intravascular imaging in tibial vessel interventions. The evaluation of OCT is primarily to: (a) establish feasibility and reproducibility in below-the-knee vessels, (b) determine the optimal protocol imaging to produce the optimal clear image frame and clear image length, (c) provide detailed lesion characteristics of tibial disease, (d) assess for luminal gain post-intervention. Operator-determined sizing will be compared against University Hospitals Core Imaging Laboratory assessment of OCT, IVUS (when applicable), and quantitative vessel analysis (QVA). Subjects will follow up per routine care with corresponding ankle-brachial index and toe-brachial index at 1, 3, 6, and 12 months or as clinically indicated. Wound and amputation data will be collected at the pre-procedural visit and with each subsequent visit. Wound care will be managed by our wound care associates in podiatry, vascular medicine, vascular surgery, or plastic surgery.

Interventions

Compare optical coherence tomography lesion sizing and characteristics compared to traditional digital subtraction angiography

Sponsors

Abbott Medical Devices
CollaboratorINDUSTRY
University Hospitals Cleveland Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \>18 * Patients with presence of Rutherford IV-VI * Presence of ≥1 tibial artery involvement requiring endovascular treatment

Exclusion criteria

* Patients who do not have tibial disease appropriate for intervention * Estimated glomerular filtration rate \<30 mL/min not on hemodialysis

Design outcomes

Primary

MeasureTime frameDescription
Standardized Technique for OCT Use in the Lower Limb12 monthsTo develop a protocolized, reproducible technique to maximize the Clear Image Length (CIL) on 75 mm pullbacks using 100% contrast in the tibial arteries. The goal is to compare intravascular ultrasound (IVUS) and optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.

Secondary

MeasureTime frameDescription
Vessel Characteristics: Minimal Lumen Area12 monthsminimal lumen area (mm\^2)
Vessel Characteristics: Reference Vessel Diameter12 monthsreference vessel diameter (mm)
Vessel Characteristics: Reference Vessel Area12 monthsreference vessel area (mm\^2)
Vessel Characteristics: Percentage Stenosis12 monthspercentage stenosis (%) on pre-intervention imaging
Plaque Characteristics: Morphology12 monthsPercentage composition of calcium, fibrous, or lipid plaque (%)
Plaque Characteristics: Calcium Arc12 monthsCalcium arc (degree)
Comparison of Percent Contrast12 monthsCIL in 100% contrast versus 50% contrast/heparinized saline mixture
Plaque Characteristics: Fibrous cap12 monthsdepth of fibrous cap (micron)
Attenuation12 monthsMeasurement of attenuation coefficient (μ OCT) to quantify the strength of interaction of light and tissue
Vessel Characteristics Following Intervention: Luminal Gain12 monthsPost-intervention luminal gain (%), plaque modification, and dissections
Vessel Characteristics Following Intervention: Plaque Modification12 monthsReduction in calcium depth (%) if atherectomy is performed
Vessel Characteristics Following Intervention: Dissections12 monthsQualitative description of dissections seen on post-intervention imaging
Plaque Characteristics: Calcium Depth12 monthsdepth of calcium (micron)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026